HAIER BIOMEDICAL(SH:688139) Sou Hu Cai Jing·2025-08-20 03:37Core Viewpoint - The collaboration between Haier Biomedical and RAM Medical Group marks a significant step in China's medical technology companies' global expansion, focusing on technology innovation and localized services in Southeast Asia [1][3]. Group 1: Strategic Collaboration - Haier Biomedical signed a strategic cooperation agreement with RAM Medical Group, one of Thailand's major private hospital groups, to enhance automation in pharmacies and smart healthcare solutions [1][3]. - The partnership aims to implement pharmacy automation solutions, including outpatient pharmacy automation systems and smart inventory management modules, to improve efficiency and safety in medical services [4][5]. Group 2: Market Potential in Southeast Asia - Southeast Asia, with a population of 670 million and over 10% elderly population growth, is becoming a key market for medical industry expansion [3]. - Thailand, as a regional medical hub, has a pressing need for upgrades in pharmacy automation and smart medical devices, providing a strategic entry point for Chinese medical technology companies [3][4]. Group 3: Customized Solutions and Local Operations - Haier Biomedical focuses on customized solutions tailored to the Southeast Asian market, addressing local climate, medical processes, and policy standards [4][5]. - The company has established localized operational centers covering marketing, logistics, and after-sales services, transitioning from a product-selling model to a service-oriented approach [5][6]. Group 4: Broader Implications for Chinese Medical Technology - The collaboration is seen as a model for the upgrade of the Southeast Asian medical industry, showcasing a shift from cost-based competition to value-driven innovation [6]. - Haier Biomedical's approach emphasizes technology-driven standards and patient experience, positioning Chinese medical technology as a leader rather than a follower in the global market [6].